Highlighting Triglycerides, APOC3 and Cardiovascular Health – New Data presented at ESC 2026

New research highlights a close connection between elevated triglycerides, inflammation, and cardiovascular health. Our clinical data show that patients with higher fasting triglyceride levels have a more inflammatory and metabolically unhealthy profile, along with poorer cardiovascular function. Meanwhile, our Phase 1 results for RBD5044, an APOC3-targeting siRNA, demonstrate that substantial and long-lasting triglyceride reduction is […]
Ribo presents 2026 Interim results

Accelerated platform value realisation, continued expansion of global partnerships, steady advancement of core pipeline programmes, continued progress in extrahepatic delivery technologies, and AI-enabled siRNA drug discovery and development.